Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
Neuropharmacology
|
November 1, 1992
Effects of cholinergic agonists on regional brain energy metabolism in the scopolamine-treated rat
C A Ray, J Blin, T N Chase, et al.
Neurology
|
October 1, 1995
Levodopa-induced dyskinesias are improved by fluoxetine
F Durif, M Vidailhet, A M Bonnet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 1, 1991
Does ageing aggravate parkinsonian disability?
J Blin, B Dubois, A M Bonnet, et al.
Journal Francais D'Ophtalmologie
|
June 2, 2026
[Diagnostic value of visual evoked potential in toxic and nutritional optic neuropathies]
J Blin, C Marks, I Bouacha, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 1, 1992
Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET
J Blin, M J Vidailhet, B Pillon, et al.
Neuroscience Letters
|
January 2, 1991
PET studies of [18F]methyl-MK-801, a potential NMDA receptor complex radioligand
J Blin, A Denis, T Yamaguchi, et al.
Neurology
|
April 1, 1991
Nootropic drugs in Alzheimer's disease: symptomatic treatment with pramiracetam
J J Claus, C Ludwig, E Mohr, et al.
Journal of the Neurological Sciences
|
May 1, 1994
Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography
J Blin, M F Piercey, M E Giuffra, et al.
Neurology
|
August 1, 1995
The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease
B Pillon, J Blin, M Vidailhet, et al.
Archives of Neurology
|
July 1, 1990
Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations
J Blin, J C Baron, B Dubois, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
Neuropharmacology
|
November 1, 1992
Effects of cholinergic agonists on regional brain energy metabolism in the scopolamine-treated rat
C A Ray, J Blin, T N Chase, et al.
Neurology
|
October 1, 1995
Levodopa-induced dyskinesias are improved by fluoxetine
F Durif, M Vidailhet, A M Bonnet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 1, 1991
Does ageing aggravate parkinsonian disability?
J Blin, B Dubois, A M Bonnet, et al.
Journal Francais D'Ophtalmologie
|
June 2, 2026
[Diagnostic value of visual evoked potential in toxic and nutritional optic neuropathies]
J Blin, C Marks, I Bouacha, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 1, 1992
Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET
J Blin, M J Vidailhet, B Pillon, et al.
Neuroscience Letters
|
January 2, 1991
PET studies of [18F]methyl-MK-801, a potential NMDA receptor complex radioligand
J Blin, A Denis, T Yamaguchi, et al.
Neurology
|
April 1, 1991
Nootropic drugs in Alzheimer's disease: symptomatic treatment with pramiracetam
J J Claus, C Ludwig, E Mohr, et al.
Journal of the Neurological Sciences
|
May 1, 1994
Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography
J Blin, M F Piercey, M E Giuffra, et al.
Neurology
|
August 1, 1995
The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease
B Pillon, J Blin, M Vidailhet, et al.
Archives of Neurology
|
July 1, 1990
Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations
J Blin, J C Baron, B Dubois, et al.
Page
of 4